Veterinary Medicines

Virbagen canis SHA/L, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Canine distemper virus, strain Lederle VR128, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
Download as PDF

Product identification

Medicine name:
Virbagen canis SHA/L, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Canine distemper virus, strain Lederle VR128, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    7330.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain Lederle VR128, Live
    5.00
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    6910.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    6.00
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-20108
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/06/2019
Updated on: 3/05/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/04/2020
Updated on: 3/05/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/06/2019
Updated on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."